<p>(<b>A</b>) IL2/PHA PBMCs were infected with HIV-1 BaL at an MOI of 0.002, and p24 levels were measured in the supernatants after 24, 48, and 72 hours of infection. (<b>B</b>) IL2/PHA PBMCs were pretreated with AZT at increasing doses 30 min before infection with HIV-1 BaL at an MOI of 0.002. Levels of p24 were measured in the supernatants 72 hours post infection by ELISA. (<b>C, D</b>) IL2/PHA PBMCs were transfected with ssDNA (2 µg/mL) (<b>C</b>) 4 hours before or (<b>D</b>) 24 hours after infection with HIV-1. Supernatants were harvested 72 hours post infection and p24 levels measured by ELISA. Data are shown as mean of triplicates +/− SD. Similar results were obtained in three or more independent experiments. Mock, Lipofectamine.</p
<p>(A-C) PBMCs from healthy donors were activated using anti-CD3/CD28 beads and IL2 (30 U/ml) for 3 ...
<p>HIV-1 p24 production kinetics in MDM was shown for1690 M (A) and1690 T and 1175 M and 1175 T (B)....
<p>Specific disruption of the NF-κB or NFAT5 binding sites in the HIV-1 subtype B LTR inhibits R5-tr...
<p>(<b>A–D</b>) IL2/PHA PBMCs were transfected with HIV-derived ssDNA and dsDNA (2 µg/mL), or infect...
<p>A. HeLa cells were co-transfected with the infectious clone pNL4-3 and the pU2A construct at diff...
<p>A: iDCs and mDCs were infected with HIV-1<sub>Ba-L</sub>, and HIV replication was measured by the...
<p>HEK293 cells grown in 96-well plates were co-transfected with 1 μg of each vector-driven siRNA (p...
<p>Replication of NL4-3 Ba-L in PHA stimulated PBMC from healthy donors homozygous for the 1604 and ...
Objectives—After DNA or RNA virus infection, cytosolic foreign DNA or RNA derived from the infecting...
<p><b>(A)</b> Schematic representation of the experimental design and conditions: PBMC from healthy ...
OBJECTIVE: To evaluate HIV-1 DNA load in PBLs and monocytes from both long-term HAART-treated and an...
<p>(a) Flow cytometry analysis of p24 intracellular expression in iDCs (CD40<sup>+</sup>), either un...
OBJECTIVE: To evaluate HIV-1 DNA load in PBLs and monocytes from both long-term HAART-treated and an...
OBJECTIVE: To evaluate HIV-1 DNA load in PBLs and monocytes from both long-term HAART-treated and an...
<p>(A) Jurkat cells were infected with either the NL43 wild-type (WT) or Nef-defective (ΔNef) viruse...
<p>(A-C) PBMCs from healthy donors were activated using anti-CD3/CD28 beads and IL2 (30 U/ml) for 3 ...
<p>HIV-1 p24 production kinetics in MDM was shown for1690 M (A) and1690 T and 1175 M and 1175 T (B)....
<p>Specific disruption of the NF-κB or NFAT5 binding sites in the HIV-1 subtype B LTR inhibits R5-tr...
<p>(<b>A–D</b>) IL2/PHA PBMCs were transfected with HIV-derived ssDNA and dsDNA (2 µg/mL), or infect...
<p>A. HeLa cells were co-transfected with the infectious clone pNL4-3 and the pU2A construct at diff...
<p>A: iDCs and mDCs were infected with HIV-1<sub>Ba-L</sub>, and HIV replication was measured by the...
<p>HEK293 cells grown in 96-well plates were co-transfected with 1 μg of each vector-driven siRNA (p...
<p>Replication of NL4-3 Ba-L in PHA stimulated PBMC from healthy donors homozygous for the 1604 and ...
Objectives—After DNA or RNA virus infection, cytosolic foreign DNA or RNA derived from the infecting...
<p><b>(A)</b> Schematic representation of the experimental design and conditions: PBMC from healthy ...
OBJECTIVE: To evaluate HIV-1 DNA load in PBLs and monocytes from both long-term HAART-treated and an...
<p>(a) Flow cytometry analysis of p24 intracellular expression in iDCs (CD40<sup>+</sup>), either un...
OBJECTIVE: To evaluate HIV-1 DNA load in PBLs and monocytes from both long-term HAART-treated and an...
OBJECTIVE: To evaluate HIV-1 DNA load in PBLs and monocytes from both long-term HAART-treated and an...
<p>(A) Jurkat cells were infected with either the NL43 wild-type (WT) or Nef-defective (ΔNef) viruse...
<p>(A-C) PBMCs from healthy donors were activated using anti-CD3/CD28 beads and IL2 (30 U/ml) for 3 ...
<p>HIV-1 p24 production kinetics in MDM was shown for1690 M (A) and1690 T and 1175 M and 1175 T (B)....
<p>Specific disruption of the NF-κB or NFAT5 binding sites in the HIV-1 subtype B LTR inhibits R5-tr...